Saturday - November 22, 2025

LumaKa Pets® Disposable Litter Boxes Reach #4 on Amazon, #1 on Walmart in First Year with Eco-Friendly Innovation

“We recognized that traditional plastic and metal litter boxes create an impossible hygiene situation where constant scrubbing actually makes the problem worse by creating micro-scratches that harbor odor-causing bacteria,” said LumaKa Pets® founder Lou Fernandez. “Our disposable litter boxes made … Continue reading

Diabetic Macular Edema Pipeline Drugs Landscape Report 2025: MOA Analysis, R&D Progress, Clinical Trial Pipeline, and Strategic Market Evolution

DelveInsight’s “Diabetic Macular Edema Pipeline Insight 2025” report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Diabetic Macular Edema pipeline landscape. It covers the Diabetic Macular Edema pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading

Eczema Pipeline Drugs Landscape Report 2025: MOA Analysis, R&D Progress, Clinical Trial Pipeline, and Strategic Market Evolution

DelveInsight’s, “Eczema Pipeline Insight, 2025” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Eczema pipeline landscape. It covers the Eczema pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Eczema pipeline therapeutics … Continue reading

Type 1 Diabetes Pipeline Drugs Landscape Report 2025: MOA Analysis, R&D Progress, Clinical Trial Pipeline, and Strategic Market Evolution

DelveInsight’s, “Type 1 Diabetes Pipeline Insight, 2025” report provides comprehensive insights about 85+ companies and 100+ pipeline drugs in Type 1 Diabetes pipeline landscape. It covers the Type 1 Diabetes pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading

Acute Respiratory Distress Syndrome Pipeline Drugs Landscape Report 2025: MOA Analysis, R&D Progress, Clinical Trial Pipeline, and Strategic Market Evolution

DelveInsight’s, “Acute Respiratory Distress Syndrome Pipeline Insights 2025” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Acute Respiratory Distress Syndrome pipeline landscape. It covers the Acute Respiratory Distress Syndrome pipeline drug profiles, including clinical and nonclinical … Continue reading